Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin in Healthy Male and Female Subjects (Open-label, Fixed-sequence)

Trial Profile

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin in Healthy Male and Female Subjects (Open-label, Fixed-sequence)

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Atorvastatin (Primary) ; Faldaprevir (Primary) ; Itraconazole (Primary) ; Rosuvastatin (Primary)
  • Indications Acute coronary syndromes; Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Heart failure; Hepatitis C; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Mycoses; Myocardial infarction; Myocardial ischaemia; Onychomycosis; Retinal vascular occlusion; Stroke; Vulvovaginal candidiasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Apr 2013 Planned End Date changed from 1 Apr 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 30 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top